Medical Device
Manufacturing
THE TRADE PAPER OF THE FACTORY FLOOR
Z-1017-2019Class II

Fructosamine Control 1, FR2994 This product is intended for in vitro use in the calibration of the Randox...

Randox Laboratories, Limited / initiated 2018-12-03 / Open, Classified / root cause: manufacturing process

Randox Laboratories Ltd. began a recall of Fructosamine Control 1, FR2994 This product is intended for in vitro use in the calibration of the Randox Liquid Fructosamine assay on clinical chemistry... on . FDA classified it as Class II and gives the reason as "The firm is conducting a Device Modification for Fructosamine Calibrator, Fructosamine Control 1 and Control 3 for the lots specified. The assigned value of Fructosamine in this calibrator and controls has now been...". As of , the recall status on record is Open, Classified, and MDM tags the root cause as manufacturing process.

Recall record

Recall number
Z-1017-2019
Classification
Class II
Status
Open, Classified
Initiated
Posted
Recalling firm
Randox Laboratories, Limited
Product
Fructosamine Control 1, FR2994 This product is intended for in vitro use in the calibration of the Randox Liquid Fructosamine assay on clinical chemistry systems.
Product code
JJX Single (Specified) Analyte Controls (Assayed And Unassayed)
Reason for recall
The firm is conducting a Device Modification for Fructosamine Calibrator, Fructosamine Control 1 and Control 3 for the lots specified. The assigned value of Fructosamine in this calibrator and controls has now been re-assigned by a decrease of 25%.
Root cause tag
manufacturing process
FDA root cause
Under Investigation by firm
Action
The firm, Randox, notified the US distributor via email on 3 Dec 2018 with an "Urgent Medical Device Correction" letter dated 26 Nov 2018. The distributors and customers were instructed to remove the Value Sheet from existing stock and replace with the new Value Sheet and Important Notice. Customers were asked to take the following actions: " Please review all remaining stock and add the attached important notice to each kit. Replace the kit value sheet with the revised document provided. " Discuss the contents of this notice with your Medical Director. " Please retain this letter with your laboratory records and forward this letter to those who may have received this product. " Complete and return the response form to [email protected] within five working days. If you have any questions or concerns, please contact Randox Technical Services by email: [email protected] or +44 (0)28 9442 2413 or Tel: +1 304 728 2890 Toll Free 866 4 RANDOX or Email: Cheryl.O'[email protected].
Quantity in commerce
141 kits
Distribution
US Distribution to states to: CA, ME. MI, and WV.
Product codes and lots
499FR

Enforcement reports

One row per recalled product line
FDA enforcement reports joined to recall event Z-1017-2019
Recall numberClassStatusVoluntary or mandatedReport dateClassified
Z-1016-2019Class IIOngoingVoluntary: Firm initiated
Z-1017-2019Class IIOngoingVoluntary: Firm initiated
Z-1018-2019Class IIOngoingVoluntary: Firm initiated